MedPath

ATIVAN SUBL TAB 0.5MG

ATIVAN SUBL TAB 0.5MG

Discontinued
DIN Number

00722138

Drug Class

Human

Market Date

Dec 31, 1987

Company
HC

wyeth ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00722138
AIG Number0110731003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA06 LORAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationSublingual
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

LORAZEPAMActive
Strength: 0.5 MG
Monograph: LORAZEPAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.